DESENSITIZATION TO BRENTUXIMAB VEDOTIN AFTER ANAPHYLAXIS IN HODGKIN'S LYMPHOMA

EHA Library, Rahma Belhadj Jrad, 421684

THERAPEUTIC OUTCOMES OF TUNISIAN PROTOCOLS USED IN ADULTS WITH BULKY MEDIASTINAL HODGKIN LYMPHOMA

EHA Library, Khouloud Mezghani, 421685

BENDAMUSTINE COMBINED WITH BRENTUXIMAB VEDOTIN FOR THE TREATMENT OF RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA

EHA Library, Rahma Belhadj Jrad, 421686

HODGKIN LYMPHOMA PRESENTING AS A TWELVE-YEAR OLD CERVICAL ADENOPATHIC CONGLOMERATE

EHA Library, Juan Eirís del Río, 421687

DOES THE ADDITION OF BRENTUXIMAB VEDOTIN TO SALVAGE THERAPY BEFORE TRANSPLANTATION AFFECT TRANSPLANT SUCCESS IN HODGKIN LYMPHOMA PATIENTS ? SINGLE CENTRE, PRELIMINARY RESULTS

EHA Library, Taner Tan, 421688

LACK OF PROGNOSTIC IMPACT OF RISK GROUPS IN PATIENTS WITH HODGKIN LYMPHOMA (HL) TREATED WITH ESCALATED BEACOPP - LONG TERM FOLLOW-UP OF A SINGLE CENTER EXPERIENCE

EHA Library, Igor Aurer, 421689

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HODGKIN LYMPHOMA RESPONSIVE TO PD-1 BLOCKADE: A REAL-WORLD ANALYSIS OF THE “RETE EMATOLOGICA PUGLIESE” (REP)

EHA Library, Francesco Gaudio, 421690

REAL WORLD EXPERIENCE OF HODGKIN LYMPHOMA IN A TERTIARY CARE CENTRE IN NORTH INDIA

EHA Library, Tejasvini Vaid, 421691

OPEN-LABEL PHASE 1 STUDY TO EVALUATE SAFETY OF SGN-35C IN ADULTS WITH SELECT RELAPSED/REFRACTORY LYMPHOMAS (SGN35C-001; TRIAL IN PROGRESS)

EHA Library, Swetha Kambhampati, 421692

BEACOPP-R REGIMEN TOXICITY IN HODGKIN LYMPHOMA PATIENTS: A TUNISIAN RETROSPECTIVE UNICENTRIC STUDY.

EHA Library, Khouloud Mezghani, 421693

ROLE OF 18 FDG PET/CT IN THE INITIAL STAGING AND MANAGEMENT OF PATIENTS WITH HODGKIN'S LYMPHOMA: A SINGLE-CENTER STUDY IN THE CLINICAL HEMATOLOGY DEPARTMENT OF MONASTIR

EHA Library, yasmine bnouni, 421694

SERUM IGM LEVELS AT DIAGNOSIS OF PATIENTS WITH HODGKIN LYMPHOMA (HL): CORRELATIONS WITH CLINICOPATHOLOGICAL FEATURES AND OUTCOMES

EHA Library, Theodoros Vassilakopoulos, 421695

KEYFORM-008: A PHASE 3 STUDY OF COFORMULATED FAVEZELIMAB AND PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA REFRACTORY TO ANTI–PD-1 THERAPY

EHA Library, David Lavie, 421696

PET-GUIDED DE-ESCALATION STRATEGY IN THE TREATMENT OF ADVANCED STAGE HODGKIN LYMPHOMA: A SINGLE MOROCCAN CENTER RETROSPECTIVE COMPARISON

EHA Library, Mahtat EL MEHDI, 421697

OUTCOME OF LYMPHADENOPATHY WITH NORMAL BLOOD COUNTS IN CHILDREN, SINGLE CENTRE EXPERIENCE.

EHA Library, Menna Shamma, 421698

OUTCOMES OF TREATMENT FOR PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AND THE ROLE OF PET-CT: A MONOCENTRIC STUDY.

EHA Library, rihab ben sghaier, 421699

INTERACTION OF CYTOCHROME P450 GENES AND THEIR CONTRIBUTION TO THE DEVELOPMENT OF HEMATOLOGICAL TOXICITY OF PROGRAM CHEMOTHERAPY IN PATIENTS WITH HODGKIN LYMPHOMA

EHA Library, Yana Shebunyaeva, 421700

PRELIMINARY RESULTS OF THE USE OF BRENTUXIMAB VEDOTIN WITH ICE IN SECOND LINE THERAPY FOR REFRACTORY/RELAPSING HODGKIN LYMPHOMA WITH AUTO-HSCT, IN THE GROUP OF PATIENTS WITH UNFAVORABLE PROGNOSIS.

EHA Library, Saule Gabbassova, 421701

(BETA-2 MICROGLOBULINE) SERUM LEVELS AND PREDICTION OF RESPONSE IN INFLAMED LYMPHOMAS WITH PD-1/PD-L1 CO-EXPRESSION TREATED WITH STANDARD CHEMOTHERAPY PLUS ANTI-PD-1

EHA Library, Maher Salamoon, 421702

REAL-LIFE TREATMENT PRACTICE AND CLINICAL OUTCOMES IN EGYPTIAN CLASSICAL HODGKIN LYMPHOMA PATIENTS: THE PROFILE STUDY

EHA Library, Hamdy A. Azim, 421703

CLINICAL PROFILE AND TREATMENT OUTCOME OF LYMPHOPLASMACYTIC LEUKEMIA (LPL) IN CURRENT ERA- A RETROSPECTIVE ANALYSIS FROM A TERTIARY CARE CENTER

EHA Library, NITIN GUPTA, 421704

A 5 YEAR RETROSPECTIVE STUDY OF T-CELL LYMPHOMA  IN ALBANIA

EHA Library, Alma Cili, 421705

THE DIAGNOSTIC VALUE OF LYMPH NODE FLOW IMMUNOTYPING IN LYMPHOMA

EHA Library, Lian Li, 421706

MANTLE CELL LYMPHOMA : DIAGNOSIS AND THERAPEUTIC ASPECTS IN  SOUTHERN TUNISIA

EHA Library, Rim Ferhi, 421707

RETROSPECTIVE STUDY TO DESCRIBE REAL-WORLD TREATMENT PATTERNS AND ASSOCIATED OUTCOMES OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) FROM THE C3I LYMPHOMA REGISTRY IN QUEBEC

EHA Library, Isabelle Fleury, 421708

MARGINAL ZONE LYMPHOMA: AN IRISH SINGLE INSTITUTION EXPERIENCE

EHA Library, Tushar Pramod, 421709

COMPARISON OF CLINICAL FEATURES AND MANAGEMENT BETWEEN CHINESE NON-IGM LPL AND WM PATIENTS

EHA Library, Yan Li, 421710

EXAMINATION AND TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN ST. PETERSBURG (RUSSIA): DATA FROM REAL-LIFE CLINICAL PRACTICE

EHA Library, Evgenii Kunevich, 421711

IMPACT OF PROGRESSION OF DISEASE WITHIN 24 MONTHS (POD24) ON FOLLICULAR LYMPHOMA TREATMENT OUTCOME. A SINGLE CENTRE RETROSPECTIVE STUDY

EHA Library, Alfred Jones, 421712

CHANGES IN T CELL SUBSETS DURING TREATMENTS ASSOCIATED WITH OUTCOMES IN NEWLY DIAGNOSED FOLLICULAR LYMPHOMA

EHA Library, Zhijuan Lin, 421713

CD38 EXPRESSION AS AN ADDITIONAL PROGNOSTIC MARKER IN MANTLE CELL LYMPHOMA.

EHA Library, Matteo D'Addona, 421714

OUTCOME OF MANTLE CELL LYMPHOMA WITH UNIFORM PROTOCOL : A NORTH INDIAN TERTIARY CARE CENTER EXPERIENCE

EHA Library, Soumyadeep Datta, 421715

RESULTS OF THERAPY FOR BCL2-R+ AND BCL2-R- FOLLICULAR LYMPHOMA

EHA Library, Ekaterina Nesterova, 421716

”REAL-LIFE” DATA OF ZANUBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA - A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Gilad Itchaki, 421717

EXPLORING THE PROGNOSTIC VALUE OF BIOLOGICAL BIOMARKERS NLR AND PLR IN NODAL MANTLE CELL LYMPHOMA

EHA Library, Victor Tomacinschii, 421718

RISK FACTORS AND TREATMENT STRATEGIES OF NON-TRAUMATIC CHYLOTHORAX IN FOLLICULAR LYMPHOMA - A CASE SERIES

EHA Library, Thomas Weber, 421719

BGB-11417-203, AN ONGOING, PHASE 2 STUDY OF SONROTOCLAX (BGB-11417), A NEXT-GENERATION BCL2 INHIBITOR, IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Jeffrey Matous, 421720

EPCORE FL-2: PHASE 3 TRIAL OF EPCORITAMAB WITH RITUXIMAB AND LENALIDOMIDE (R2) VS CHEMOIMMUNOTHERAPY OR R2 IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Kim Linton, 421721

WAVELINE-006: A PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (ZV) ALONE OR IN COMBINATION WITH NEMTABRUTINIB AS SUBSEQUENT-LINE THERAPY IN AGGRESSIVE AND INDOLENT B-CELL MALIGNANCIES

EHA Library, Wojciech Jurczak, 421722

CHIDAMIDE IN COMBINATION WITH R-CHOP FOR NEWLY DIAGNOSED B‑CELL NON-HODGKIN LYMPHOMA WITH EPIGENETIC MUTATIONS: PRELIMINARY ANALYSIS FROM THE RESULTS OF A PHASE II STUDY

EHA Library, Hongmei Jing, 421723

ASSOCIATION OF ATG16L1 RS2241880 AND TP53 RS1042522 WITH CHARACTERISTICS AND COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Andjelina Zivanovic, 421724

QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING OF LONCASTUXIMAB TESIRINE COMBINED WITH MOSUNETUZUMAB AND GLOFITAMAB HELPS GUIDE DOSING FOR PATIENTS WITH DLBCL

EHA Library, Yuezhe Li, 421725

PROGNOSTIC ROLE OF NUTRITION-RELATED FACTORS IN PRIMARY GASTROINTESTINAL DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Qiqi Qiao, 421726

INCIDENCE OF SECOND PRIMARY MALIGNANCIES (SPM) FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY (CAR-T)

EHA Library, Charles Pei, 421727

COMPARISON OF DIFFERENT PROGNOSTIC MODELS FOR ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: REAL-WORLD DATA FROM T CELL LYMPHOMA COOPERATION GROUP IN SOUTH CHINA

EHA Library, Qiuyuan Xiang, 421728

PHASE II STUDY OF ORELABRUTINIB, RITUXIMAB AND THIOTEPA (ORT) COMBINED WITH OR WITHOUT HIGH-DOSE MTX THERAPY IN PATIENTS WITH PRIMARY CNS LYMPHOMA

EHA Library, Chunmei Yang, 421730

AI-ASSISTED DIAGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA WITH BONE MARROW INVASION

EHA Library, Xuelian Wu, 421731

QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL PREDICTS COMBINATION ACTIVITY OF CD19-TARGETED LONCASTUXIMAB TESIRINE CO-DOSED WITH A CD20/CD3 T-CELL BISPECIFIC (EPCORITAMAB) IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Yuezhe Li, 421732

A FIRST-IN-HUMAN STUDY OF THE POTENT AND HIGHLY SELECTIVE BTK DEGRADER ABBV-101 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES

EHA Library, William Wierda, 421734

CNS PROPHYLAXIS, TREATMENT & OUTCOMES IN HIGH GRADE NON-HODGKIN'S LYMPHOMA: AN EIGHT-YEAR EXPERIENCE

EHA Library, Inova Lee, 421735

PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA WHO ARE POTENTIAL CANDIDATES FOR CAR T-CELL THERAPY

EHA Library, ANNA HIRATSUKA, 421736

OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‑CELL LYMPHOMA (DLBCL) TREATED WITH SYSTEMIC THERAPY FROM REAL‑WORLD EXPERIENCE (ORCHID) STUDY

EHA Library, Catherine Thieblemont, 421737

EVALUATION OF FERTILITY IN WOMEN TREATED WITH THE R-DA-EPOCH REGIMEN FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA (PMBCL)

EHA Library, Angeliki Georgopoulou, 421738

CLINICAL CHARACTERISTICS AND OUTCOMES OF EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF FEMALE GENITAL TRACK: A RETROSPECTIVE STUDY OF THE HELLENIC COOPERATIVE LYMPHOMA GROUP

EHA Library, Evgenia Verrou, 421739

THE DEFINITION AND USE OF BULK DISEASE IN PHASE 3 LYMPHOMA TRIALS: A COMPREHENSIVE LITERATURE REVIEW

EHA Library, Luke Wang, 421740

INCIDENCE AND SURVIVAL OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS OVER TWO DECADES: A DANISH POPULATION-BASED STUDY

EHA Library, Mads Okkels Birk Lorenzen, 421741

DISTINCT CHARACTERISTICS AND SOCIAL DETERMINANTS IN ADULT T-CELL LEUKEMIA/LYMPHOMA PATIENTS FROM TORONTO

EHA Library, Tomohiro Aoki, 421742

IMPACT OF RESPONSE TO STEROID ADMINISTRATION BEFORE CHEMOIMMUNOTHERAPY ON PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Kikuaki Yoshida, 421743

PRIMARY GASTROINTESTINAL LYMPHOMA – EPIDEMIOLOGY, TREATMENT, AND OUTCOMES IN A 25-YEAR SINGLE CENTER EXPERIENCE

EHA Library, Karla Misura Jakobac, 421744

R2-GDP WITH LENALIDOMIDE MAINTENANCE FOR TRANSPLANT-INELIGIBLE RELAPSE REFRACTORY DLBCL UNDER CLINICAL TRIAL AND REAL-WORLD SETTINGS

EHA Library, Lawrence Ng, 421745

IMPACT OF EXTRAMEDIASTINAL INVOLVEMENT ON SURVIVAL METRICS IN PMBCL PATIENTS: INSIGHTS FROM A UNIFORM R-DA-EPOCH PROTOCOL

EHA Library, Runiza Abdurashidova, 421746

OUTCOMES OF PEDIATRIC AND YOUNG ADULTS’ PATIENTS TREATED FOR LYMPHOBLASTIC LYMPHOMA BY EORTC 58859 PROTOCOL– A SINGLE CENTER EXPERIENCE.

EHA Library, Imen Ben Amor, 421747

TREATMENT OUTCOMES OF R-CHOP WITHOUT RADIOTHERAPY FOR UNTREATED LIMITED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: SUPPLEMENTARY ANALYSIS OF JCOG0601

EHA Library, Yo Saito, 421748

MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN: SUBGROUP ANALYSES IN PATIENTS (PTS) WITH PRIMARY REFRACTORY OR EARLY RELAPSED LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Manali Kamdar, 421749

INCIDENCE RATES AND TRENDS OF LARGE B-CELL LYMPHOMA IN SPAIN (2002-2016): A POPULATION-BASED STUDY

EHA Library, rafael marcos-gragera, 421751

PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA: OWN EXPERIENCE OF DIAGNOSIS AND EFFECTIVE TREATMENT PROTOCOLS.

EHA Library, Liliya Gorenkova, 421752

A RETROSPECTIVE STUDY ON THE USE OF R-COMP IN TREATMENT OF DLBCL PATIENTS: WHEN A SAMPLE IS NOT BIAS SELECTED

EHA Library, Luigi Rigacci, 421753

REVIEW OF NATIONWIDE INPATIENT REGISTRY TO ANALYZE THE RISK AND OUTCOMES OF TUMOR LYSIS SYNDROME OF PATIENT ADMITTED FOR AGGRESSIVE B CELL LYMPHOMAS.

EHA Library, Muhammad Farooq, 421754

A DIAGNOSTIC PREDICTIVE MODEL FOR DISTINGUISHING INTRAVASCULAR LARGE B-CELL LYMPHOMA IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN

EHA Library, Chao Chen, 421755

TAFASITAMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE US REAL-WORLD SETTING

EHA Library, Kimberly Saverno, 421756

EFFICACY AND SAFETY OF POLA-R-CHP THERAPY IN ELDERLY PATIENTS OVER 80 YEARS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD OBSERVATIONAL STUDY

EHA Library, Masaaki Hotta, 421757

COMPARATIVE EFFECTIVENESS OF NHL-BFM-90 AND R-CHOEP CHEMOTHERAPY PROTOCOLS IN HIV-INFECTED PATIENTS WITH BURKITT'S LYMPHOMA

EHA Library, Chingiz Mabudzada, 421758

SELINEXOR IN COMBINATION WITH R-EPOCH FOR PATIENTS WITH PREVIOUSLY UNTREATED HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA(DLBCL)

EHA Library, Chaoyu Wang, 421759

THE IMPACT OF INTENSIVE CHEMOTHERAPY AND RADIOTHERAPY ON PLASMABLASTIC LYMPHOMA OUTCOMES

EHA Library, Philip Haddad, 421760

ZANBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF OLDER UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARDGE B CELL LYMPHOMA

EHA Library, Hui Liu, 421761

CONSTRUCTION OF A PREDICTIVE MODEL FOR SURVIVAL RISK IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA BASED ON MACHINE LEARNING

EHA Library, Liping Su, 421762

T-CELL/HISTOCYTE B-CELL RICH LYMPHOMA (THRBCL) TREATMENT WITH R-CHOEP PLUS VENETOCLAX (SURVIVAL ADVANTAGE)

EHA Library, Maher Salamoon, 421763

SELINEXOR COMBINED WITH TISLELIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA (R/R ENKTL): RESULTS OF DOSE ESCALATION OF COHORT C FROM PHASE I/II STUDY TOUCH

EHA Library, Rong Tao, 421764

ZANUBRUTINIB IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH POOR PROGNOSTIC GENETIC MUTATIONS: A PROPENSITY SCORE MATCHED ANALYSIS

EHA Library, Wenrong Huang, 421765

EFFICIENCY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED PATIENTS WITH DOUBLE EXPRESSOR DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Xiaojing Xing, 421766

THE EFFICACY OF HIGH DOSE METHOTREXATE IN THE PROPHYLAXIS OF CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AT HIGH RISK : A RETROSPECTIVE BICENTRIC STUDY IN REAL LIFE.

EHA Library, CAILLET Adrien, 421767

CENTRAL NERVOUS SYSTEM INVOLVEMENT IN EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA: A RETROSPECTIVE STUDY OF A CONSECUTIVE 13-YEAR CASE SERIES

EHA Library, Liang Wang, 421768

REAL WORLD DATA OF ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULT PATIENTS WITH REFRACTORY/RELAPSED HIGH GRADE B CELL LYMPHOMA AND MANTLE CELL LYMPHOMA IN ONE CENTRE IN SOUTHERN GREECE.

EHA Library, Stavros Papadakis, 421769

MITOXANTRONE HYDROCHLORIDE LIPOSOME, GEMCITABINE, VINORELBINE WITH OR WITHOUT RITUXIMAB (GVM±R) IN PATIENTS WITH RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN'S LYMPHOMA

EHA Library, Wei Liu, 421770

EXPLORING FRONTIERS: A DECADE OF EARLY PHASE CLINICAL TRIALS AT A LEADING TERTIARY CENTER.

EHA Library, SERGIO RAMOS, 421771

REAL-LIFE STUDY OF POLATUZUMAB VEDOTIN, BENDAMUSTINE AND RITUXIMAB FOR STAGE IV HIGH-INTERMEDIATE/HIGH RISK DLBCL OR INDOLENT TRANSFORMED IN RELAPSED/REFRACTORY SITUATION

EHA Library, Andre Pardal, 421772

THE LONG-TERM IMPACT OF RITUXIMAB-BASED CHEMOIMMUNOTHERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, REAL WORLD OUTCOMES USING NATIONAL HEALTH INSURANCE DATABASE OF SOUTH KOREA.

EHA Library, Hyun Jung Lee, 421774

COMBINATION OF MITOXANTRONE HYDROCHLORIDE LIPOSOME WITH CYCLOPHOSPHAMIDE, VINCRISTINE, ETOPOSIDE AND PREDNISONE (CMOEP) IN TREATMENT-NAIVE PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A PHASE ONE STUDY

EHA Library, Jingwei Yu, 421775

SAFETY AND EFFICACY OF AUTOLOGOUS HSCT IN ELEVEN PATIENTS WITH AIDS-RELATED NON-HODGKIN LYMPHOMA

EHA Library, Jun Liu, 421776

EFFICACY AND SAFETY ANALYSIS OF COMBINATION THERAPY BASED ON MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION IN RELAPSED/REFRACTORY NK/T-CELL LYMPHOMA

EHA Library, Liang Wang, 421777

« LONG-TERM RESULTS OF TREATMENT OF PATIENTS WITH THE PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (PCNSL) ACCORDING TO THE “CNS-2015” STUDY»

EHA Library, Daria Koroleva, 421778

ACUTE KIDNEY INJURY WITHIN 30 DAYS FOLLOWING CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA

EHA Library, John Sharp, 421779

PHASE 2 SEARCH STUDY：SELINEXOR (ATG-010) MONOTHERAPY IN HEAVILY PRETREATED CHINESE PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Song Yuqin, 421780

CONFIRMATION OF THE EXCELLENT OUTCOMES WITH BRENTUXIMAB-NIVOLUMAB FOR RELAPSED REFRACTORY PRIMARY MEDIASTINAL B-CELL LYMPHOMA IN THE REAL-WORLD SETTING

EHA Library, Lucy Pickard, 421781

REAL-WORLD EXPERIENCE OF GLOFITAMAB THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Liudmila Fedorova, 421782

CLINICAL OUTCOME AND PROGNOSTIC FACTORS OF ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: A RETROSPECTIVE SINGLE CENTRE STUDY

EHA Library, Yu Peng, 421783

ASSOCIATION OF PAKT1 AND AIF BIOMARKERS WITH THE PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Vaneeva, 421784

ACALABRUTINIB IN COMBINATION WITH RITUXIMAB AND REDUCED DOSE CHOP (R-MINICHOP) IN OLDER ADULTS WITH UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA – ARCHED/GLA 2022-1, A GERMAN LYMPHOMA ALLIANCE STUDY

EHA Library, Igor Age Kos, 421785

A RETROSPECTIVE STUDY ON THE EFFICACY AND SAFETY OF CHIDAMIDE AS MAINTENANCE THERAPY OF PERIPHERAL T-CELL LYMPHOMA (PTCL)(NCT05967949)

EHA Library, Haorui Shen, 421786

SEQUENTIAL CD19/22 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY LARGE B-CELL NON-HODGKIN'S LYMPHOMA

EHA Library, Caixia Li, 421787